Bolt Biotherapeutics logo

Bolt Biotherapeutics

BOLT | NASDAQ
Chart Builder DCF Calculator
$5.80
-$0.28 (-4.61%)
At close: Nov 16, 2026, 4:00 PM ET
$5.80
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:15 PM ET
-4.61%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
29.8
+3.0 pts
Fundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #797/1021 (Top 78%)

Key Statistics

Market Data

Market Cap $11.17M
1D Range
5.61 6.05
52W Range
3.18 7.09

Valuation (TTM)

PE -0.40
PB 1.30
EV/EBITDA -0.68

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $4.00
Loading financial charts...

Profile

Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the b...

Sector Healthcare
Industry Biotechnology
Employees 23
IPO Date Feb 5, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$2.25
Beat +38.86%
REV
$450K
Beat 0.00%
Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$4.00
Downside
-31.03%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.